Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. GOVERNMENT REGULATIONS

3.4.1. FDA
3.4.2. CE Mark
3.4.3. Therapeutic Goods Administration (TGA)
3.4.4. Ministry of Health, Labour and Welfare (MHLW)

3.5. MARKET SHARE ANALYSIS, 2016
3.6. VACCINE PRODUCT AND PIPELINE ANALYSIS
3.7. CLINICAL TRIALS BY KEY PLAYERS
3.8. MARKET DYNAMICS

3.8.1. Drivers

3.8.1.1. High prevalence of diseases
3.8.1.2. Increase in government focus on immunization programs
3.8.1.3. Emerging vaccines
3.8.1.4. Technological progress in vaccine administration

3.8.2. Restraints

3.8.2.1. Longer timelines required for vaccine production
3.8.2.2. High costs associated with the development of vaccines

3.8.3. Opportunity

3.8.3.1. High growth prospects in emerging markets

Chapter: 4 VACCINES MARKET, BY TECHNOLOGY

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CONJUGATE VACCINES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. INACTIVATED VACCINES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. LIVE ATTENUATED VACCINES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. TOXOID VACCINES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. RECOMBINANT VACCINES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHER VACCINES

4.7.1. Market size and forecast

Chapter: 5 VACCINES MARKET, BY END USE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PEDIATRIC VACCINES

5.2.1. Market size and forecast

5.3. ADULT VACCINES

5.3.1. Market size and forecast

5.4. TRAVELER VACCINES

5.4.1. Market size and forecast

Chapter: 6 VACCINES MARKET, BY INDICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. PNEUMOCOCCAL DISEASE

6.2.1. Market size and forecast

6.3. INFLUENZA

6.3.1. Market size and forecast

6.4. HUMAN PAPILLOMA VIRUS

6.4.1. Market size and forecast

6.5. MENINGOCOCCAL DISEASE

6.5.1. Market size and forecast

6.6. ROTAVIRUS

6.6.1. Market size and forecast

6.7. VARICELLA

6.7.1. Market size and forecast

6.8. DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT)

6.8.1. Market size and forecast

6.9. POLIO

6.9.1. Market size and forecast

6.10. HEPATITIS

6.10.1. Market size and forecast

6.11. MEASLES, MUMPS, AND RUBELLA (MMR)

6.11.1. Market size and forecast

6.12. OTHER INDICATIONS

6.12.1. Market size and forecast

Chapter: 7 VACCINES MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. UK market size and forecast
7.3.5. France market size and forecast
7.3.6. Germany market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Argentina market size and forecast
7.5.6. Turkey market size and forecast
7.5.7. South Africa market size and forecast
7.5.8. Rest of LAMEA market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. ASTELLAS PHARMA INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. ASTRAZENECA PLC (MEDIMMUNE, LLC)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. CSL LIMITED

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. EMERGENT BIOSOLUTIONS, INC.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. GLAXOSMITHKLINE PLC

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. JOHNSON & JOHNSON

8.6.1. Company overview
8.6.2. Company Snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. MERCK & CO., INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. PFIZER INC.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. SANOFI

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. SERUM INSTITUTE OF INDIA PVT. LTD.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Product portfolio
8.10.4. Key strategic moves and developments